Status Of Ranitidine Drugs In Canada

Ranitidine Recall Summary Health Canada removed ranitidine products from the market because testing found they contained an impurity called NDMA that could increase cancer risk with long-term exposure. The recall affected all ranitidine medications sold in Canada, including brand names like Zantac. Canadians who were taking ranitidine for heartburn or acid reflux were affected by this action.

Category
consumer product recall
Country
Canada
Agency
HC-PRODUCTS
Recall date
2020-07-23
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/bb3b8a38-d2bf-41e8-9c08-ef8cb1813375